Metagenomi
5 known investors
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations. It focuses on developing genetic medicines to treat diseases with well-understood biology.
BiotechDeep TechMedical Devices
Investors · 5
Frequently asked questions
- What does Metagenomi do?
- Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations. It focuses on developing genetic medicines to treat diseases with well-understood biology.
- Who are Metagenomi's investors?
- Metagenomi's investors include Catalio Capital Management, LP, RA Capital, Sozo Ventures, Agent Capital, Humboldt.